NYSE · MDT
Medtronic Plc
$97.11+$2.33 (+2.46%)
Medtronic Plc’s quoted price sits in the upper half of its reported 52-week range, 8.67% below the high.
Loading market information…
NYSE · ZBH · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Zimmer Biomet Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 6.01% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zimmer Biomet Holdings, Inc.’s forward annual dividend is $0.96 per share, paid quarterly. The forward yield is 0.98% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Zimmer Biomet Holdings, Inc.’s next earnings report is currently expected on Nov 4, 2026, with estimated earnings per share of $1.88. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zimmer Biomet Holdings, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:10 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q1 2025 | May 5, 2025 | $1.81+2.26% vs estimate | $1.91B+0.73% vs estimate |
|---|
| Q4 2024 | Feb 6, 2025 | $2.31+0.43% vs estimate | $2.02B+0.44% vs estimate |
|---|
| Q3 2024 | Oct 30, 2024 | $1.740.0% vs estimate | $1.82B+1.44% vs estimate |
|---|
THE ANALYST VIEW
42 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 7 contributors · Median target $104.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$97.11+$2.33 (+2.46%)
Medtronic Plc’s quoted price sits in the upper half of its reported 52-week range, 8.67% below the high.
$311.36+$7.36 (+2.42%)
Stryker Corporation’s quoted price sits in the lower half of its reported 52-week range, 20.03% below the high.
$42.69+$0.26 (+0.61%)
Boston Scientific Corporation’s quoted price sits in the lower half of its reported 52-week range, 59.59% below the high.
$94.44+$2.66 (+2.9%)
Edwards Lifesciences Corporation’s quoted price sits in the upper half of its reported 52-week range, 1.92% below the high.
$76.42+$0.60 (+0.79%)
GE HealthCare Technologies Inc.’s quoted price sits in the upper half of its reported 52-week range, 14.87% below the high.
$27.12+$0.09 (+0.33%)
Koninklijke Philips N.V.’s quoted price sits in the lower half of its reported 52-week range, 18.9% below the high.
¥2,388+¥19 (+0.8%)
Terumo Corporation’s quoted price sits in the upper half of its reported 52-week range, 11.19% below the high.
$30.41+$0.29 (+0.96%)
Smith & Nephew plc’s quoted price sits in the lower half of its reported 52-week range, 18.01% below the high.
